PHXM
PHAXIAM Therapeutics S.A.
NASDAQ: PHXM · HEALTHCARE · BIOTECHNOLOGY
$3.10
+0.00% today
Updated 2026-05-01
Market cap
$28.90M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-39.05
Dividend yield
—
52W range
$0 – $0
Volume
—
PHAXIAM Therapeutics S.A. (PHXM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+100.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2023-09-30 | $-0.23 | $0.00 | +100.0% | — | — |
| 2023-06-30 | $-0.22 | $0.00 | +100.0% | — | — |
| 2023-03-31 | $-0.21 | $0.00 | +100.0% | — | — |
| 2022-12-31 | $-0.19 | $0.00 | +100.0% | — | — |
| 2022-09-30 | $-0.35 | $-0.35 | -0.8% | — | — |
| 2022-06-30 | $-0.37 | $0.30 | +179.7% | — | — |
| 2022-03-31 | $-0.37 | $0.00 | +100.0% | — | — |
| 2021-12-31 | $-0.39 | $-0.39 | +0.0% | — | — |
| 2021-09-30 | $-0.69 | $-0.64 | +7.5% | — | — |
| 2021-06-30 | $-0.58 | $-0.78 | -34.4% | — | — |
| 2021-03-31 | $-0.96 | $-0.67 | +30.3% | — | — |
| 2020-12-31 | $-1.08 | $-1.28 | -18.5% | — | — |
Frequently asked questions
Has PHAXIAM Therapeutics S.A. beaten earnings estimates?
PHAXIAM Therapeutics S.A. has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +100.0% over the last 4 quarters.